FY2024 EPS Estimates for Insmed Boosted by Cantor Fitzgerald
Insmed Incorporated (NASDAQ:INSM – Free Report) – Stock analysts at Cantor Fitzgerald raised their FY2024 EPS estimates for shares of Insmed in a note issued to investors on Wednesday, February 19th. Cantor Fitzgerald analyst J. Kim now expects that the biopharmaceutical company will post earnings of ($5.41) per share for the year, up from their […]
Insmed Incorporated (NASDAQ:INSM – Free Report) – Stock analysts at Cantor Fitzgerald raised their FY2024 EPS estimates for shares of Insmed in a note issued to investors on Wednesday, February 19th. Cantor Fitzgerald analyst J. Kim now expects that the biopharmaceutical company will post earnings of ($5.41) per share for the year, up from their […]
